45 related articles for article (PubMed ID: 11843628)
1. Occurrence of DNA sequences specifically recognized by drugs in human promoters.
Mansilla S; Portugal J
J Biomol Struct Dyn; 2002 Feb; 19(4):669-79. PubMed ID: 11843628
[TBL] [Abstract][Full Text] [Related]
2. Selective binding of small molecules to DNA: application and perspectives.
Wang B; Tan J; Zhu L
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):1-4. PubMed ID: 20447811
[TBL] [Abstract][Full Text] [Related]
3. Systematic search for the Cra-binding promoters using genomic SELEX system.
Shimada T; Fujita N; Maeda M; Ishihama A
Genes Cells; 2005 Sep; 10(9):907-18. PubMed ID: 16115199
[TBL] [Abstract][Full Text] [Related]
4. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
5. Chimpanzee, orangutan, mouse, and human cell cycle promoters exempt CCAAT boxes and CHR elements from interspecies differences.
Müller GA; Heissig F; Engeland K
Mol Biol Evol; 2007 Mar; 24(3):814-26. PubMed ID: 17205977
[TBL] [Abstract][Full Text] [Related]
6. UV light as a footprinting agent: modulation of UV-induced DNA damage by transcription factors bound at the promoters of three human genes.
Tornaletti S; Pfeifer GP
J Mol Biol; 1995 Jun; 249(4):714-28. PubMed ID: 7602584
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
8. REPSA: combinatorial approach for identifying preferred drug-DNA binding sequences.
Van Dyke MW
Methods Mol Biol; 2010; 613():193-205. PubMed ID: 19997885
[TBL] [Abstract][Full Text] [Related]
9. Mode of selectivity in cyclic AMP receptor protein-dependent promoters in Escherichia coli.
Pyles EA; Lee JC
Biochemistry; 1996 Jan; 35(4):1162-72. PubMed ID: 8573570
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial determination of sequence specificity for nanomolar DNA-binding hairpin polyamides.
Vashisht Gopal YN; Van Dyke MW
Biochemistry; 2003 Jun; 42(22):6891-903. PubMed ID: 12779344
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in the actions of drugs that bind in the DNA minor groove.
Albert FG; Eckdahl TT; Fitzgerald DJ; Anderson JN
Biochemistry; 1999 Aug; 38(31):10135-46. PubMed ID: 10433722
[TBL] [Abstract][Full Text] [Related]
12. Composition-sensitive analysis of the human genome for regulatory signals.
Kel-Margoulis OV; Tchekmenev D; Kel AE; Goessling E; Hornischer K; Lewicki-Potapov B; Wingender E
In Silico Biol; 2003; 3(1-2):145-71. PubMed ID: 12954097
[TBL] [Abstract][Full Text] [Related]
13. Clustering of DNA sequences in human promoters.
FitzGerald PC; Shlyakhtenko A; Mir AA; Vinson C
Genome Res; 2004 Aug; 14(8):1562-74. PubMed ID: 15256515
[TBL] [Abstract][Full Text] [Related]
14. [Levels in the structural organization of Escherichia coli promoter DNA].
Ozolin' ON; Deev AA; Masulis IS; Chasov VV; Kostianitsyna EG; Purtov IuA; Arkhipov IV; Brok-Volchanskiĭ AS
Biofizika; 2002; 47(5):809-19. PubMed ID: 12397950
[TBL] [Abstract][Full Text] [Related]
15. In vitro transcription assay for resolution of drug-DNA interactions at defined DNA sequences.
Evison BJ; Phillips DR; Cutts SM
Methods Mol Biol; 2010; 613():207-22. PubMed ID: 19997886
[TBL] [Abstract][Full Text] [Related]
16. Cyclopentenone causes cell cycle arrest and represses cyclin D1 promoter activity in MCF-7 breast cancer cells.
Hsiang CH; Straus DS
Oncogene; 2002 Mar; 21(14):2212-26. PubMed ID: 11948404
[TBL] [Abstract][Full Text] [Related]
17. Analysis of gene structures and promoter activities of the chipmunk alpha(1)-antitrypsin-like genes.
Nakazawa A; Inaba Y; Kamijima A; Kondo N; Ito M; Shiba T; Takamatsu N
Gene; 2004 Mar; 329():71-9. PubMed ID: 15033530
[TBL] [Abstract][Full Text] [Related]
18. The Evi-1 zinc finger myeloid transforming protein binds to genomic fragments containing (GATA)n sequences.
Matsugi T; Kreider BL; Delwel R; Cleveland JL; Askew DS; Ihle JN
Oncogene; 1995 Jul; 11(1):191-8. PubMed ID: 7624127
[TBL] [Abstract][Full Text] [Related]
19. Methylation status and chromatin structure of an early response gene (ornithine decarboxylase) in resting and stimulated NIH-3T3 fibroblasts.
Laitinen J; Hölttä E
J Cell Biochem; 1994 Jun; 55(2):155-67. PubMed ID: 7522236
[TBL] [Abstract][Full Text] [Related]
20. A consensus DNA recognition motif for two KDWK transcription factors identifies flexible-length, CpG-methylation sensitive cognate binding sites in the majority of human promoters.
Burnett E; Christensen J; Tattersall P
J Mol Biol; 2001 Dec; 314(5):1029-39. PubMed ID: 11743720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
